Description

Molotinib 100mg Tablet (Momelotinib) – Uses, Side Effects, Dosage & Price in Pakistan

Molotinib 100mg Tablet (Momelotinib) is an oral medicine used in the treatment of certain forms of myelofibrosis, a serious bone marrow disorder associated with abnormal blood-cell production, enlarged spleen and anemia. Momelotinib belongs to a group of medicines called kinase inhibitors and works on signaling pathways involved in myelofibrosis.

Molotinib 100mg Tablet should only be used under the supervision of a specialist experienced in treating blood and bone marrow disorders. The appropriate strength and dose depend on the patient’s condition, blood counts, liver function, previous treatment and response to therapy.

Molotinib 100mg Tablet (Momelotinib) Uses

Molotinib 100mg Tablet may be prescribed for adults with intermediate- or high-risk myelofibrosis who have anemia. This includes primary myelofibrosis as well as secondary myelofibrosis that develops after polycythemia vera or essential thrombocythemia.

Depending on the patient’s disease and previous treatment, momelotinib may help address important problems associated with myelofibrosis, including:

• Anemia associated with myelofibrosis
• Enlarged spleen (splenomegaly)
• Myelofibrosis-related symptoms
• Abnormal signaling that contributes to disease progression

The UK product information also describes use in adults with moderate-to-severe anemia and disease-related splenomegaly or symptoms who are either JAK-inhibitor naïve or have previously received ruxolitinib.

How Molotinib 100mg Tablet (Momelotinib) Works

Momelotinib is a kinase inhibitor that affects signaling pathways involved in myelofibrosis. By inhibiting abnormal signaling, it can help reduce disease-related symptoms and spleen enlargement while also having an effect on anemia in appropriate patients.

Because myelofibrosis is a complex blood and bone marrow disease, the response to Molotinib 100mg Tablet can vary between patients. Regular medical follow-up is therefore important.

Molotinib 100mg Tablet Dosage

The current U.S. prescribing information recommends momelotinib 200mg once daily, taken orally with or without food. Momelotinib is available in 100mg, 150mg and 200mg tablet strengths. Therefore, a 100mg tablet should not automatically be interpreted as the standard adult daily dose.

In patients with severe hepatic impairment, the current U.S. label recommends a reduced starting dose of 150mg once daily. Dose adjustments or interruptions may also be required depending on blood counts and adverse reactions.

Your doctor may change the prescribed strength or temporarily stop treatment based on laboratory results and treatment tolerance. Do not increase, decrease or stop Molotinib on your own.

How to Take Molotinib 100mg Tablet

Molotinib is taken by mouth once daily according to the prescribed regimen. It can generally be taken with or without food. Try to take it at approximately the same time each day.

Swallow the tablet whole with water. Do not crush, chew or split the tablet unless your healthcare professional specifically instructs you to do so.

If you miss a dose, follow your doctor’s or pharmacist’s instructions rather than taking an extra dose.

Molotinib 100mg Tablet Side Effects

Like other prescription medicines, Molotinib 100mg Tablet can cause side effects. Some commonly reported reactions include:

• Low platelet count
• Bleeding
• Bacterial infections
• Tiredness
• Dizziness
• Diarrhea
• Nausea
• Headache
• Rash or itching
• Swelling
• Blurred vision
• Joint or muscle discomfort

The current FDA patient information identifies low platelet counts, bleeding, bacterial infection, fatigue, dizziness, diarrhea and nausea among the common side effects.

Not every patient experiences these effects, and their severity can differ.

Serious Warnings and Precautions

Molotinib requires careful monitoring because it can affect blood counts, liver function and the body’s ability to fight infections.

Infections

Momelotinib can increase the risk of serious infections. Treatment should not be started in patients with an active infection, and patients should be monitored for signs of infection, including possible hepatitis B reactivation.

Low Platelets and Neutropenia

The medicine can cause thrombocytopenia and neutropenia. Your doctor may reduce the dose, interrupt treatment or discontinue it depending on the severity of the blood-count changes.

Liver Problems

Liver tests should be performed before treatment and periodically during therapy. Patients with liver disease should tell their doctor before starting treatment.

Blood Clots and Cardiovascular Events

Patients should seek urgent medical attention for symptoms such as sudden chest pain, breathing difficulty or swelling and pain in a leg. The current labeling includes warnings regarding major cardiovascular events and thrombosis.

Symptoms After Stopping Treatment

Symptoms of myelofibrosis may worsen after momelotinib is interrupted or discontinued. Treatment should not be stopped suddenly without medical advice.

Drug Interactions with Molotinib 100mg Tablet

Tell your doctor about every prescription medicine, over-the-counter product, vitamin and herbal supplement you use.

Current FDA information identifies OATP1B1/B3 inhibitors as an important interaction group because they may increase momelotinib exposure and the risk of adverse reactions. Momelotinib can also increase exposure to certain BCRP substrate medicines, including rosuvastatin.

Your healthcare professional may need to monitor you more closely or adjust treatment when these medicines are used together.

Pregnancy and Breastfeeding

Momelotinib may harm an unborn baby. Patients who are pregnant, planning pregnancy or who become pregnant during treatment should discuss the situation with their healthcare provider. Current patient information advises avoiding pregnancy during treatment and for one week after the final dose.

Breastfeeding is also not recommended during treatment and for one week after the final dose according to current patient information.

Monitoring During Molotinib Treatment

Regular laboratory testing is an important part of treatment. Your doctor may monitor:

• Complete blood counts
• Platelet levels
• Liver function
• Signs of infection
• Symptoms related to bleeding or thrombosis
• Overall response to treatment

Blood tests are performed before and during therapy, and the dose may be changed according to results and tolerability.

Molotinib 100mg Tablet Storage

Keep Molotinib in its original container and store it according to the product’s packaging instructions. Current U.S. information for momelotinib tablets recommends room-temperature storage and protection from excess moisture. Keep the medicine tightly closed and away from children.

Molotinib 100mg Tablet Price in Pakistan

The Molotinib 100mg Tablet price in Pakistan can vary depending on the manufacturer, pack size, import status, availability and pharmacy or supplier. Imported oncology medicines may also have changing prices because of supply and exchange-rate differences.

For the latest availability and current pricing, patients can contact Impo Medic and confirm the exact product, strength, pack size and availability before placing an order.

How to Buy Molotinib 100mg Tablet in Pakistan

If you are looking to buy Molotinib 100mg Tablet in Pakistan, make sure the medicine comes from a reliable pharmaceutical supplier and that the packaging, strength, batch information and expiry date are checked before use.

Impo Medic can help patients check medicine availability and product details. Because momelotinib is a specialist medicine for myelofibrosis, it should be purchased and used according to a qualified healthcare professional’s prescription.

Frequently Asked Questions

What is Molotinib 100mg Tablet (Momelotinib) used for?

Molotinib contains momelotinib and is used for certain forms of intermediate- or high-risk myelofibrosis in adults with anemia.

Is 100mg the usual dose of Molotinib?

Not necessarily. Although momelotinib is available as a 100mg tablet, the current U.S. recommended adult dose is 200mg once daily. The exact regimen must be determined by the treating specialist.

Can Molotinib be taken with food?

Yes. Current prescribing information states that momelotinib can be taken with or without food.

What are the common side effects of Molotinib?

Common side effects can include low platelet counts, bleeding, infections, tiredness, dizziness, diarrhea and nausea.

Can I stop Molotinib suddenly?

You should not stop or interrupt treatment without speaking with your doctor because symptoms of myelofibrosis may worsen after treatment is stopped.

Is Molotinib available in Pakistan?

Availability can vary by supplier and stock status. For current product availability and pricing information in Pakistan, patients can contact Impo Medic.

Who should prescribe Molotinib 100mg Tablet?

Molotinib should be prescribed and monitored by a healthcare professional experienced in treating myelofibrosis and other blood or bone marrow disorders.